Historical salary details - Ms. Anna Protopapas, Chairman of the board, Nuvalent Inc - Ordinary Shares - Class A
Ms. Anna Protopapas is the Chairman of the board of Nuvalent Inc - Ordinary Shares - Class A. They also hold 1 other positions in and Mersana Therapeutics Inc.
Ms. Anna Protopapas
Chairman of the board
$ 627.9 K
Gross Remuneration
-
Current Company
Nuvalent Inc - Ordinary Shares - Class A
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Nuvalent Inc - Ordinary Shares - Class A | Chairman of the board | 481.9 K | -7.9 % |
| 2024 | Mersana Therapeutics Inc | Director | 146.0 K | - |
| 2023 | Nuvalent Inc - Ordinary Shares - Class A | Independent Director | 523.2 K | -5.5 % |
| 2023 | Mersana Therapeutics Inc | Director | - | - |
| 2023 | Mersana Therapeutics Inc | Director | - | - |
| 2022 | Nuvalent Inc - Ordinary Shares - Class A | Independent Director | 553.7 K | - |
| 2022 | Mersana Therapeutics Inc | President, Chief Executive Officer and Director | - | - |
| 2021 | Mersana Therapeutics Inc | President, Chief Executive Officer and Director | - | - |
| 2021 | Nuvalent Inc - Ordinary Shares - Class A | Chairman of the Board | - | - |
| 2020 | Mersana Therapeutics Inc | President, Chief Executive Officer and Director | - | - |
| 2019 | Mersana Therapeutics Inc | President, Chief Executive Officer and Director | - | - |
| 2018 | Mersana Therapeutics Inc | President, Chief Executive Officer and Director | - | - |
| 2017 | Mersana Therapeutics Inc | President, Chief Executive Officer and Director | - | - |
| 2016 | Mersana Therapeutics Inc | President, Chief Executive Officer and Director | - | - |